General and administrative (G&A) expenses were $12.4 million for the first quarter of 2025, which included $5.1 million of restructuring expenses in March 2025. Non-cash stock-based compensation ...

The first quarter 2025 financial results and business update will be discussed during a conference call and webcast presentation today at 2:30 pm CET/8:30 am ET. A webcast of the live call may be ...

Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsChristine Chiou - Senior Vice President, ...

Registrational studies are currently ongoing in three subsets of myositis, thyroid eye disease (TED), and Sjögren’s disease. Topline results from ALKIVIA study evaluating three myositis subsets ...

Patients with and without generalized ligamentous laxity had comparable outcomes 5 years after hip arthroscopy. Survivorship at 5-year follow-up was 98.3%. WASHINGTON — Hip arthroscopy may yield ...